Back to KRYS
Elmind Capital, LP KRYS Position History
Krystal Biotech, Inc. • Healthcare
Quarters held
4
Latest value
$7.3M
Q3 2026
Peak value
$8.2M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $5.4M |
| Q1 2026 | $5.7M |
| Q2 2026 | $8.2M |
| Q3 2026 | $7.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $7.3M | 22.0K | — | — |
| Q2 2026 | $8.2M | 22.0K | — | — |
| Q1 2026 | $5.7M | 22.0K | — | — |
| Q4 2025 | $5.4M | 22.0K | — | — |
Other funds holding KRYS
$1.2B
$1.1B
$1.1B
$960.7M
$857.3M
$814.4M
$774.3M